SURAKSHASuraksha Diagnostic Limited
Convert to ideaHealthcare · Healthcare Services
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 0.6 this quarter.
Momentum from moving averages, Supertrend and RSI.
3 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
3 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹99 Cr | ₹15 Cr | 22.42% | 15.09% | ₹2.88 | 4.9x |
| Q1 FY2027 | ₹88 Cr | ₹13 Cr | 21.86% | 14.65% | ₹2.50 | 5.4x |
| Q4 FY2026 | ₹81 Cr | ₹6 Cr | 16.10% | 7.55% | ₹1.21 | 3.6x |
| Q3 FY2026 | ₹78 Cr | ₹7 Cr | 16.21% | 9.32% | ₹1.44 | 4.2x |
| Q2 FY2026 | ₹79 Cr | ₹9 Cr | 17.73% | 11.20% | ₹1.73 | 5.3x |
| Q1 FY2026 | ₹73 Cr | ₹9 Cr | 19.65% | 12.63% | ₹1.80 | 5.6x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Services
Compare with peers →Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.